Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
20%
ALSO IN PPH
PPH
27
HOLDINGS
42%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.6% | 20.0% | 7.6% |
|
MERCK & CO. INC. | 7.1% | 9.9% | 7.1% |
|
BRISTOL-MYERS SQUIBB CO | 6.7% | 4.8% | 4.8% |
|
ABBVIE INC | 7.5% | 4.7% | 4.7% |
|
JOHNSON & JOHNSON | 7.1% | 4.5% | 4.5% |
FTXH Overweight Relative to PPH
|
BIOGEN IDEC INC | 3.5% |
|
CARDINAL HEALTH INC | 3.4% |
|
AMGEN INC | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 3.2% |
|
GILEAD SCIENCES INC | 2.9% |
|
ABBVIE INC | 2.9% |
|
REGENERON PHARMACEUTICALS | 2.8% |
|
VIATRIS, INC. | 2.7% |
|
JOHNSON & JOHNSON | 2.7% |
|
UNITED THERAPEUTICS CORP | 2.6% |
FTXH Underweight Relative to PPH
|
ELI LILLY & CO | -12.3% |
 |
NOVARTIS AG-ADR | -10.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.4% |
|
MCKESSON CORP | -4.5% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
ASTRAZENECA PLC-SPONS ADR | -3.8% |
|
CENCORA INC | -3.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -3.1% |
|
MERCK & CO. INC. | -2.8% |